Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients
Medicare officials said they would cover Biogen Inc.’s BIIB 2.64% controversial Alzheimer’s disease drug Aduhelm on the condition that patients...
Medicare officials said they would cover Biogen Inc.’s BIIB 2.64% controversial Alzheimer’s disease drug Aduhelm on the condition that patients...
A California judge said the November ballot measure that allowed Uber Technologies Inc., Lyft Inc. and DoorDash Inc. to continue...
The Biden administration took steps Wednesday to crack down on rising Covid-19 cases, including a call for a third shot...